CraigDanielSeamanMD

PubMed

• Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease.
  Craig D Seaman> ;Blood Coagulation & Fibrinolysis. 2023 Oct 1
• Intravascular Lymphoma - The Creepy Crawler: A Case Series and Brief Literature Review.
  Kainat Saleem, Azadeh Nasrazadani, Chaoyuan Kuang, Vanya Jaitly, Jonhan Ho, Anastasios Raptis, Roy Smith, Craig Seaman> ;Cancer Diagnosis & Prognosis. 2023 Jan 3
• Von Willebrand Disease in Older Patients: A Retrospective Electronic Health Record Review.
  Craig D Seaman> ;Clinical and Applied Thrombosis/hemostasis. 2022 Dec 20
• 15 citations
  A case of acquired haemophilia A in a 70-year-old post COVID-19 vaccine.
  Chantal Lemoine, Alaina Giacobbe, Eliana Bonifacino, Lilit Karapetyan, Craig D. Seaman> ;Haemophilia. 2021 Oct 28
• 3 citations
  Hemophilia A (Factor VIII Deficiency).
  Craig D. Seaman, Frederico Xavier, Margaret V. Ragni> ;Hematology/oncology Clinics of North America. 2021 Aug 10
• 3 citations
  Quality of periprocedural care in patients with von Willebrand disease.
  Craig D. Seaman, Marnie Bertolet, Jun Zhang, Margaret V. Ragni> ;Haemophilia. 2021 Aug 3
• 1 citations
  Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 cros...
  Craig D. Seaman, Jonathan G. Yabes, Christina M. Lalama, Margaret V. Ragni> ;Haemophilia. 2021 May 1
• 3 citations
  Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
  Craig D. Seaman, Enrico M. Novelli, Laura M. De Castro, Margaret V. Ragni> ;Pilot and Feasibility Studies. 2020 Nov 10
• 5 citations
  Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A.
  Patrick T. Ebbert, Frederico Xavier, Lynn M. Malec, Craig D. Seaman, Margaret V. Ragni> ;Thrombosis Research. 2020 Nov 1
• 8 citations
  The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand Disease.
  Craig D. Seaman, Margaret V. Ragni> ;Thrombosis and Haemostasis. 2020 Jul 6
• 56 citations
  Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors.
  Patrick T. Ebbert, Frederico Xavier, Craig D. Seaman, Margaret V. Ragni> ;Haemophilia. 2020 Jan 1
• 30 citations
  Emicizumab use in major orthopedic surgery
  Craig D. Seaman, Margaret V. Ragni> ;Blood Advances. 2019 Jun 11
• 3 citations
  Periprocedural management of von Willebrand disease: An institutional experience
  Craig D. Seaman, Margaret V. Ragni> ;Haemophilia. 2019 May 1
• 9 citations
  The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease
  Craig D. Seaman, Margaret V. Ragni> ;Clinical and Applied Thrombosis/hemostasis. 2018 Apr 1
• 7 citations
  Prevalence and Risk Factors Associated With Hypertension in von Willebrand Disease
  Mariya Apostolova, Craig D. Seaman, Diane M. Comer, Jonathan G. Yabes, Margaret V. Ragni> ;Clinical and Applied Thrombosis/hemostasis. 2018 Jan 1
• 2 citations
  Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis.
  Craig D. Seaman, Margaret V. Ragni> ;Blood Advances. 2017 Jul 25
• 8 citations
  Feasibility of the Von Willebrand disease PREVENT trial.
  Margaret V. Ragni, Nicoletta Machin, Andra H. James, Craig D. Seaman, Lynn M. Malec, Craig M. Kessler, Barbara A. Konkle, Peter A. Kouides, Anne T. Neff, Claire S. Phi...> ;Thrombosis Research. 2017 Aug 1
• 12 citations
  Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities...
  Craig D. Seaman, Kristen M. George, Margaret V. Ragni, Aaron R. Folsom> ;Thrombosis Research. 2016 Aug 1
• 7 citations
  Prevalence and Risk Factors Associated With Hypertension in Hemophilia: Cross-Sectional Analysis of a National Discharge Register.
  Craig D. Seaman, Mariya Apostolova, Jonathan G. Yabes, Diane M. Comer, Margaret V. Ragni> ;Clinical and Applied Thrombosis/hemostasis. 2017 Oct 1
• 3 citations
  Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction
  Margaret V. Ragni, Donna DiMichele, C. M. Hay, Lynn M. Malec, Craig D. Seaman, Jie Li, Jonathan G. Yabes, Saulius Butenas, Kathleen E. Brummel-Ziedins> ;Haemophilia. 2016 Mar 1
• 33 citations
  Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register
  Craig D. Seaman, Jonathan Yabes, Diane M. Comer, Margaret V. Ragni> ;Journal of Thrombosis and Haemostasis. 2015 Nov 1
• 31 citations
  Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.
  Craig D. Seaman, Jonathan Yabes, Jie Li, Charity G. Moore, Margaret V. Ragni> ;Thrombosis Research. 2014 Dec 1
• 34 citations
  Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective
  Craig D. Seaman, Kenneth J. Smith, Margaret V. Ragni> ;Thrombosis Research. 2013 Dec 1
• 58 citations
  SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells
  Manu Kohli, Jian Yu, Craig D. Seaman, Alberto Bardelli, Kenneth W. Kinzler, Bert Vogelstein, Christoph Lengauer, Lin Zhang> ;Proceedings of the National Academy of Sciences of the United States of America. 2004 Nov 30
• Join now to see all

Abstracts/Posters

• Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
  Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Emicizumab Prophylaxis in Patients with Hemophilia _ with and without Inhibitors
  Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019